Circulating CLL cells with trisomy 12 have increased expression of the surface integrins CD11a, CD11b and CD18, which are down‐regulated in the presence of NOTCH1 mutations (Riches et al, 2014). The gene discussed is NOTCH1; the disease is B-cell chronic lymphocytic leukemia.